TORUS BIOSYSTEMS INC
Brookline, MA · Founded 2019 · CIK 0001802637 · Medtech · Private
Synestia qPCR diagnostic platform with multiplexed pathogen and resistance gene detection for point-of-care UTI testing
torus.bio →- Grants
- $600K
- 2 awards
- Sector median: 1
- Raised
- $29M
- 3 Form D · May 2021
- 65 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2019202020212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,500,000 | |
| Private capital raised | Form D · SEC | $2,000,000 | |
| Private capital raised | Form D · SEC | $25,214,240 | |
| Federal grant | Department of Health and Human Services · Phase I · A highly multiplexed convection flow qPCR assay and platform delivering rapid, comprehensive identification and predictive AST of pathogens causing UTIs. | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · A highly multiplexed convection flow qPCR assay and platform delivering rapid, comprehensive identification and predictive AST of pathogens causing UTIs. | $300,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1397 | AerBetic, Inc. | — | $100K |
| 1398 | Hura Imaging, Inc. | — | $250K |
| 1399 | MICROELASTIC ULTRASOUND SYSTEMS, INC. | — | — |
| 1400 | TORUS BIOSYSTEMS INC | — | $29M |
| 1401 | REDOLYNT, LLC | — | — |
| 1402 | MedicaMetrix, Inc/DE | — | $3.2M |
| 1403 | CoapTech, LLC | — | $19M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Philip GardellaExecutive Officer
- Ben LindenExecutive Officer
- Shawn MarcellDirector · Executive Officer
- Chenyang Victor ShiDirector
- Adam WiechhausDirector
- Peng YinDirector · Executive Officer
- David ZhangDirector
- David Yu ZhangDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.